BPG is committed to discovery and dissemination of knowledge
Articles in Press
9/21/2022 10:30:35 PM | Browse: 58 | Download: 51
Publication Name World Journal of Cardiology
Manuscript ID 78704
Country Croatia
Category Cardiac & Cardiovascular Systems
Manuscript Type Letter to the Editor
Article Title Euglycemic diabetic ketoacidosis: A rare but serious side effect of sodium-glucose co-transporter 2 inhibitors
Manuscript Source Unsolicited Manuscript
All Author List Nenad Lakušić, Ivana Sopek Merkaš, Ana Marija Slišković and Dora Cerovec
Funding Agency and Grant Number
Corresponding Author Ivana Sopek Merkaš, MD, Doctor, Department of Cardiology, Special Hospital for Medical Rehabilitation Krapinske Toplice, 2 Gajeva, Krapinske Toplice 49217, Croatia. ivana.sopek@sbkt.hr
Key Words Sodium-glucose co-transporter 2 inhibitors; Euglycemic diabetic ketoacidosis; Chronic heart failure
Core Tip Sodium-glucose co-transporter 2 inhibitors have recently become an established treatment for most chronic heart failure (CHF) patients (with and without diabetes), and it is important for the cardiologist to know their side effects, including those that are rare, but serious, like euglycemic ketoacidosis. In this way, an unwanted outcome of CHF treatment can be avoided.
Citation Lakušić N, Sopek Merkaš I, Slišković AM, Cerovec D. Euglycemic diabetic ketoacidosis: A rare but serious side effect of sodium-glucose co-transporter 2 inhibitors World J Cardiol 2022; 14(10): 561-564
Received
2022-07-10 22:35
Peer-Review Started
2022-07-10 22:36
To Make the First Decision
Return for Revision
2022-08-22 00:59
Revised
2022-08-29 23:48
Second Decision
2022-09-20 03:34
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2022-09-21 22:30
Articles in Press
2022-09-21 22:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2022-10-13 09:18
ISSN 1949-8462 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com